Canada markets close in 6 hours 15 minutes

Alpha Cognition Inc. (ACOGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.8600-0.0343 (-3.84%)
As of 03:55PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.8943
Open0.8761
BidN/A x N/A
AskN/A x N/A
Day's Range0.8600 - 0.8827
52 Week Range0.6761 - 1.8000
Volume5,171
Avg. Volume13,947
Market Cap52.59M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3780
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Alpha Cognition Announces Participation in January Investor Conferences

    VANCOUVER, British Columbia, January 03, 2022--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is scheduled to participate in the following investor conferences in January 2022:

  • Business Wire

    Alpha Cognition Announces Director Change and Stock Option Grant

    VANCOUVER, B.C., December 27, 2021--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced the resignation of Dr. Fred Sancilio from his role as Director and President of the Company. Dr. Sancilio will continue to work with Alpha Cognition as a consultant focusing on ALPHA-1062’s bi

  • CNW Group

    Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

    Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the December 16th Life Sciences Virtual Investor Conference are now available for on-demand viewing.